Alan T. Yeo

2.9k total citations · 3 hit papers
14 papers, 1.8k citations indexed

About

Alan T. Yeo is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Alan T. Yeo has authored 14 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Alan T. Yeo's work include Glioma Diagnosis and Treatment (4 papers), Immune cells in cancer (4 papers) and Natural product bioactivities and synthesis (3 papers). Alan T. Yeo is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Immune cells in cancer (4 papers) and Natural product bioactivities and synthesis (3 papers). Alan T. Yeo collaborates with scholars based in United States and Australia. Alan T. Yeo's co-authors include Vassiliki A. Boussiotis, Anthos Christofides, Laura Strauss, Alain Charest, Carol Cao, Jeffrey A. Engelman, Mari Mino–Kenudson, Cyril H. Benes, Lecia V. Sequist and A. John Iafrate and has published in prestigious journals such as Nature Immunology, PLoS ONE and Biochemistry.

In The Last Decade

Alan T. Yeo

13 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

2012 976 citations Ryohei Katayama, Alice T. Shaw et al. Science Translational Medicine profile →
The complex role of tumor-infiltrating macrophages

2022 560 citations Anthos Christofides, Laura Strauss et al. Nature Immunology profile →
Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression

2022 153 citations Alan T. Yeo, Shruti Rawal et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan T. Yeo United States	10	931	888	867	496	382	14	1.8k
Molly J. DeCristo United States	8	1.1k 1.2×	675 0.8×	637 0.7×	456 0.9×	288 0.8×	10	1.7k
Yongping Song China	16	717 0.8×	459 0.5×	866 1.0×	440 0.9×	256 0.7×	28	1.7k
Li-Chuan Chan Taiwan	17	1.2k 1.2×	425 0.5×	965 1.1×	779 1.6×	406 1.1×	27	2.1k
Peter Kabos United States	31	1.5k 1.6×	828 0.9×	1.0k 1.2×	206 0.4×	740 1.9×	100	2.5k
April A. N. Rose Canada	21	998 1.1×	372 0.4×	958 1.1×	336 0.7×	307 0.8×	57	1.9k
Maarten Slagter Netherlands	7	1.4k 1.5×	411 0.5×	598 0.7×	937 1.9×	373 1.0×	9	2.0k
Jaclyn Sceneay Australia	18	1.4k 1.5×	607 0.7×	1.2k 1.4×	1.0k 2.0×	756 2.0×	21	2.7k
Xuanwen Bao China	23	506 0.5×	1.2k 1.3×	1.2k 1.4×	336 0.7×	1.0k 2.6×	52	2.2k
Luigi Formisano Italy	25	1.1k 1.2×	772 0.9×	1.1k 1.3×	165 0.3×	494 1.3×	73	2.2k
Yoshimi Arima Japan	27	906 1.0×	291 0.3×	1.2k 1.4×	239 0.5×	396 1.0×	46	2.0k

Countries citing papers authored by Alan T. Yeo

Since Specialization

Citations

This map shows the geographic impact of Alan T. Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan T. Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan T. Yeo more than expected).

Fields of papers citing papers by Alan T. Yeo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan T. Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan T. Yeo. The network helps show where Alan T. Yeo may publish in the future.

Co-authorship network of co-authors of Alan T. Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of Alan T. Yeo. A scholar is included among the top collaborators of Alan T. Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan T. Yeo. Alan T. Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Paulo, João A., Tomer M. Yaron, Jared L. Johnson, et al.. (2024). Pleiotropic tumor suppressive functions of PTEN missense mutations during gliomagenesis. iScience. 27(12). 111278–111278.

Yeo, Alan T., Rinku Pal, Shruti Rawal, et al.. (2023). Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma. Cancer Immunology Research. 11(5). 629–645. 15 indexed citations

Yeo, Alan T., Shruti Rawal, Bethany Delcuze, et al.. (2022). Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression. Nature Immunology. 23(6). 971–984. 153 indexed citations breakdown →

Christofides, Anthos, Laura Strauss, Alan T. Yeo, et al.. (2022). The complex role of tumor-infiltrating macrophages. Nature Immunology. 23(8). 1148–1156. 560 indexed citations breakdown →

Yeo, Alan T., Hyun Jung Jun, Vicky A. Appleman, et al.. (2021). EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma. Oncogene. 40(15). 2682–2696. 16 indexed citations

Wuerzberger‐Davis, Shelly M., et al.. (2019). CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein. PLoS ONE. 14(9). e0222588–e0222588. 9 indexed citations

Vidal, Bárbara, et al.. (2019). A high-grade glioma with SOS1 amplification. Clinical Neuropathology. 39(5). 126–134. 1 indexed citations

Yeo, Alan T. & Alain Charest. (2017). Immune Checkpoint Blockade Biology in Mouse Models of Glioblastoma. Journal of Cellular Biochemistry. 118(9). 2516–2527. 18 indexed citations

Nacci, Diane, et al.. (2016). Adaptive Significance of ERα Splice Variants in Killifish (Fundulus heteroclitus) Resident in an Estrogenic Environment. Endocrinology. 157(6). 2294–2308. 5 indexed citations

10.

Yeo, Alan T., Spandan Chennamadhavuni, Adrian Whitty, John A. Porco, & Thomas D. Gilmore. (2015). Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines. Molecules. 20(5). 7474–7494. 2 indexed citations

11.

Hata, Aaron N., Alan T. Yeo, Anthony C. Faber, et al.. (2014). Failure to Induce Apoptosis via BCL-2 Family Proteins Underlies Lack of Efficacy of Combined MEK and PI3K Inhibitors for KRAS-Mutant Lung Cancers. Cancer Research. 74(11). 3146–3156. 60 indexed citations

12.

Zhou, Li, et al.. (2014). Disulfide-Mediated Stabilization of the IκB Kinase Binding Domain of NF-κB Essential Modulator (NEMO). Biochemistry. 53(50). 7929–7944. 10 indexed citations

13.

Katayama, Ryohei, Alice T. Shaw, Tahsin Khan, et al.. (2012). Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers. Science Translational Medicine. 4(120). 120ra17–120ra17. 976 indexed citations breakdown →

14.

Yeo, Alan T., John A. Porco, & Thomas D. Gilmore. (2011). Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis. Cancer Letters. 318(1). 53–60. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact